A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction

Journal of Cardiac Failure

Volumn 10, Issue 4, 2004, Pages 316-320

  Yazaki, Yoshikazu ^a   Muhlestein, Joseph B ^a   Carlquist, John F ^a   Bair, Tami L ^a   Horne, Benjamin D ^a   Renlund, Dale G ^a   Anderson, Jeffrey L ^a  

^a LDS HOSPITAL   (United States)

Author keywords

Adenosine; Adenosine monophosphate deaminase; Cardiomyopathy; Heart failure; Ischemic heart disease; Survival

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ADULT; AGED; ALLELE; AMPD1 GENE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EVALUATION; FEMALE; GENE; GENE IDENTIFICATION; GENOTYPE; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ALLELES; AMP DEAMINASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4143134331     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.10.008     Document Type: Article

References (18)

1. Morisaki T., Gross M., Morisaki H., Pongratz D., Zollner N., Holmes E.W. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A. 89:1992;6457-6461
2. Sinkeler S.P.T., Joosten E.M.G., Wevers R.A., Oei T.L., Jacobs A.E., Veerkamp J.H., et al. Myoadenylate deaminase deficiency: a clinical, genetic, and biochemical study in nine families. Muscle Nerve. 11:1988;312-317
3. Loh E., Rebbeck T.R., Mahoney P.D., DeNofrio D., Swain J.L., Holmes E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation. 99:1999;1422-1425
4. Anderson J.L., Habashi J., Carlquist J.F., Muhlestein J.B., Horne B.D., Bair T.L., Pearson R.R., et al. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol. 36:2000;1248-1252
5. Leesar M.A., Stoddard M., Ahmed M., Broadbent J., Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507
6. The AMISTAD Investigators. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol. 34:1999;1711-1720
7. McLellan T., Jorde L.B., Skolnick M.H. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet. 36:1984;836-857
8. Anderson J.L., King G.J., Thomson M.J., Todd M., Bair T.L., Muhlestein J.B., et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol. 30:1997;1206-1211
9. Gross M. New method for detection of C34-T in the AMPD1 gene causing myoadenylate deaminase deficiency. Ann Rheum Dis. 53:1994;353-354
10. Eichhorn E.J. Prognostic determination in heart failure. Am J Med. 110:2001;14S-36S
11. Montgomery H.E., Keeling P.J., Goldman J.H., Humphries S.E., Talmud P.J., McKenna W.J. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 25:1995;1627-1631
12. Feldman A.M., Wagner D.R., McNamara D.M. AMPD1 gene mutation in congestive heart failure. Circulation. 99:1999;1397-1399
13. Sabina R.L., Holmes E.W. Myoadenylate deaminase deficiency. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited disease. 1995;1769-1780 McGraw-Hill Inc, New York
14. Dobson J.G. Jr. Adenosine and adrenergic mediated effect in the heart. Abd-Elfattah A.A., Wechsler A. Purines and myocardial protection. 1995;359-371 Kluwer Academic Publishers, Norwell (MA)
15. Dobson J.G.J., Fenton R.A., Sawmiller D.R. The contractile response of the ventricular myocardium to adenosine A1 and A2 receptor stimulation. Ann N Y Acad Sci. 793:1996;64-73
16. Ely S.W., Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation. 85:1992;893-904
17. Merdrum D.R., Cain B.S., Cleveland J.C.J., Meng X., Ayala A., Banerjee A., et al. Adenosine decreases post-ischemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology. 92:1997;472-477
18. Kitakaze M., Hori M., Kamada T. The role of adenosine and its interaction with alpha-adrenoreceptor activity in myocardial ischemic and reperfusion injury. Cardiovasc Res. 27:1993;18-27